Vancouver, Canada – March 26, 2026 – TheNewswire - Redwood AI Corp. (CSE: AIRX) (Frankfurt: Y0N, WKN: A422EZ) (the “Company”) is pleased to announce the launch date of a Mitacs Accelerate-supported research project with the University of British Columbia (UBC), delivered in collaboration with the Quantum Algorithms Institute (QAI). Redwood AI and QAI are participating as co partner organizations on the project, which is anticipated to commence in April 2026.

This research project represents an important step in Redwood’s ongoing efforts to bring emerging technologies into real-world chemical applications. By combining artificial intelligence with quantum computing methods, the project aims to support faster and more efficient approaches to chemical synthesis, with the potential to one day reduce research timelines and costs for applications such as pharmaceutical development and defense applications.

Through this research project, Redwood will work closely with QAI and UBC to integrate quantum computing techniques into AI-driven chemical synthesis workflows. As part of the project, Redwood will gain access to advanced quantum infrastructure, including hardware platforms developed by D-Wave Quantum Inc., a Nasdaq-listed quantum computing company, made available through QAI’s technology partnerships and technical support framework.

The research will focus on two high-impact applications in chemical development. The first aims to explore how quantum computing can enhance the way AI models represent and learn chemical information, with the goal of enabling more robust predictions and insight across diverse molecular spaces. The second centers on synthetic route planning, where quantum-assisted optimization methods may help identify more efficient and cost-effective pathways. Together, these challenges reflect daily bottlenecks for chemists and researchers in many fields, where improved prediction and planning can directly influence development speed, cost, and success rates. Particularly for fields such as pharmaceutical development and defense, where rapid scale up is often required. By integrating quantum approaches with modern AI, the project aims to move beyond the practical limits of conventional computational tools and support the development of scalable, reliable, and interpretable.

The project is supported through the Mitacs Accelerate program and includes a postdoctoral research placement at the University of British Columbia. The Mitacs postdoctoral intern will work closely with teams at Redwood and QAI to co-develop quantum-assisted optimization strategies. The research project also supports broader national goals in quantum innovation, talent development, and advanced manufacturing.

"Quantum computing has the potential to change how we approach some of the hardest problems in chemistry. While significant advances have been made in computational support for chemistry, including the use of artificial intelligence, existing tools and technologies aren’t able to efficiently address many remaining problems. We are excited to work with QAI and take a leadership role in bringing quantum-enhanced AI tools into the hands of chemists and drug developers," said Louis Dron, CEO of Redwood AI.

 

About the Quantum Algorithms Institute

 

The Quantum Algorithms Institute is a British Columbia‑based non‑profit organization advancing quantum computing through collaboration with government, academia, and industry. Its mission is to drive regional economic growth by fostering quantum literacy, building a skilled quantum-ready workforce, and helping organizations adopt quantum technologies effectively. Founded in 2020, QAI draws on BC’s deep ecosystem of quantum innovation to cultivate a vibrant and inclusive quantum industry focused on job creation and real-world impact.1

 

About Redwood AI Inc.

Redwood AI uses advanced artificial intelligence to accelerate chemistry R&D, with the aim of assisting in drug discovery and development, and furthering defense and safety solutions. The Company combines expertise in chemistry, AI, and manufacturing to streamline drug synthesis and scale-up. Redwood AI’s platform is designed to enable faster, more efficient development of new therapies and chemistry-driven applications.

 

ON BEHALF OF REDWOOD AI CORP.,

 

“Louis Dron”

Chief Executive Officer

 

For more information, please contact:

 

Louis Dron

Chief Executive Officer

 

Tel: +1 888 530 8488

Email: investors@redwoodai.com

 

The CSE and Information Service Provider have not reviewed and do not accept responsibility for the accuracy or adequacy of this release.

 

Forward-Looking Statements Caution.

 

This news release contains "forward-looking information" within the meaning of applicable Canadian securities legislation, including, without limitation, statements regarding the timing of commencement of trading of the Company’s Shares on the CSE and the Company’s future goals and objectives. Generally, forward-looking information can be identified by the use of forward- looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain acts, events or results "may", "could", "would", "might" or "will be taken", "occur" or "be achieved".

 

Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company, as the case may be, to be materially different from those expressed or implied by such forward-looking information, including, without limitation, risks relating to the future business plans of the Company; risks that the Company will not be able to retain its key personnel; risks that the Company’s strategy or expectations regarding its software will materialize as anticipated or at all. Accordingly, readers should not place undue reliance on any such forward-looking information.

 

Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking information. Actual results and developments may differ materially from those contemplated by these statements. The Company does not undertake to update any forward-looking information, except in accordance with applicable securities laws.

   

1 https://www.qai.ca/who-we-are